Magnetic Resonance Perfusion Diffusion Mismatch and Thrombolysis in Acute Ischaemic Stroke: A Systematic Review of the Evidence to Date
JNNP 78:485-491,443, Kane,I.,et al, 2007
Established Treatments for Acute Ischaemic Stroke
Lancet 369:319-330, Khaja,A.M. &Grotta,J.C., 2007
Has Evidence Changed Practice? Appropriateness of Carotid Endarterectomy After the Clinical Trials
Neurol 68:187-194,172, Halm,E.A.,et al, 2007
Subarachnoid Haemorrhage
Lancet 369:306-318, van Gijn,J.,et al, 2007
Comparison of CT Perfusion and Angiography and MRI in Selecting Stroke Patients for Acute Treatment
Neurol 68:694-697, Wintermark,M.,et al, 2007
Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report
Neurol 68:977-984, Goodin,D.S.,et al, 2007
Superficial Siderosis
Arch Neurol 64:491-496, Kumar,J, 2007
Gadolinium-Based MR Contrast Agents and Nephrogenic Systemic Fibrosis
Radiology 242:647-649, Kuo,P.H.,et al, 2007
Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades
Medicine 86:112-121, Taly,A.B., et al, 2007
Usefulness of Checking Platelet Count Before Thrombolysis in Acute Ischemic Stroke
Stroke 38:1639-1640, Cucchiara,B.L.,et al, 2007
Radiological Findings, Clinical Course, and Outcome in Asymptomatic Moaymoya Disease: Results of Multicenter Survey in Japan
Stroke 38:1430-1435, Kuroda,S.,et al, 2007
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts & Leukoencephalopathy (CADASIL)
UpToDate (www.uptodate.com) Aug 21, Dichgans,M.,et al., 2007
Brain Magnetic Resonance Imaging of an Adult Case of Acute Necrotizing Encephalopathy
J Neurol 254:1135-1137, Kato,H.,et al., 2007
Asymptomatic Pontine Myelinolysis
Eur J Neurol 13:1261-1263, Razvi,S.S.J. &Leach,J.P., 2006
The Stroke-Thrombolytic Predictive Instrument: A Predictive Instrument for Intravenous Thrombolysis in Acute Ischemic Stroke
Stroke 37:2957-2962,2865, Kent,D.M.,et al, 2006
Clinical Presentation and Pre-Mortem Diagnosis of Variant Creutzfeldt-Jakob Disease Associated With Blood Transfusion: A Case Report
Lancet 368:2061-2067, Wroe,S.J.,et al, 2006
Acute Necrotizing Encephalopathy of Childhood: Correlation of MR Findings and Clinical Outcome
AJNR 27:1919-1923, Wong,A.M.,et al, 2006
Spontaneous Bilateral Internal Carotid Artery Dissection with Acute Stroke in Young Patients
Eur Neurol 56:230-234, Wu,H.-C.,et al, 2006
Leukoaraiosis Is a Risk Factor for Symptomatic Intracerebral Hemorrhage After Thrombolysis for Acute Stroke
Stroke 37:2463-2466, Neumann-Haefelin,T.,et al, 2006
Vertebral Artery Dissection, Presenting Findings and Predictors of Outcome
Stroke 37:2499-2503, Arnold,M.,et al, 2006
Practice Parameter: Diagnostic Assessment of the Child with Status Epilepticus (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the practice Committee of the Child Neurology Society
Neurol 67:1542-1550, Riviello,J.J. Jr.,et al, 2006
Can Multivariable Risk-Benefit Profiling Be Used to Select Treatment-Favorable Patients for Thrombolysis in Stroke in the 3- to 6-Hour Time Window?
Stroke 37:2963-2969, Kent,D.M.,et al, 2006
Using the Baseline CT Scan to Select Acute Stroke Patients for IV-IA Therapy
AJNR 27:1612-1616, Hill,M.E.,et al, 2006
West Nile Virus Neuroinvasive Disease
Ann Neurol 60:286-300, Davis,L.E.,et al, 2006
Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
Stroke 37:852-858, Thomalla,G.,et al, 2006
Role of CT Angiography in Thrombolysis Decision-Making for Patients with Presumed Seizure at Stroke Onset
Stroke 37:915-917, Sylaja,P.N.,et al, 2006
Brain Abnormalities in Neuromyelitis Optica
Arch Neurol 63:390-396, Pittock,S.J.,et al, 2006
Perfusion CT Helps Decision Making for Thrombolysis When There is No Clear Time of Onset
JNNP 77:417-419, Hellier,K.D.,et al, 2006
The First Seizure and Its Management in Adults and Children
BMJ 332:339-342, Pohlmann-Eden,B.,et al, 2006
Standardized MR Imaging Protocol for Multiple Sclerosis:Consortium of MS Centers Consensus Guidelines
AJNR 27:455-461, Simon,J.H.,et al, 2006
Metabolic Syndrome as an Independent Risk Factor of Silent Brain Infarction in Healthy People
Stroke 37:466-470, Kwon,H.-M.,et al, 2006
Imaging-Guided Acute Ischemic Stroke Therapy: From "Time is Brain" to "Physiology is Brain"
AJNR 27:728-735, Gonzalez,R.G., 2006
Chronic Disorders of Consciousness
Lancet 367:1181-1192, Bernat,J.L., 2006
Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006
Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006
Good Outcomes in Ischemic Stroke Patients treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke 37:1332-1333, Baumann,C.R.,et al, 2006
Clinicopath Conf, Acute Ischemic Stroke
NEJM 354:2263-2271, Case 16:2006, 2006
Subarachnoid Haemorrhage
BMJ 333:235-240, Al-Shahi,R.,et al, 2006
Cerebral Aneurysms
NEJM 355:928-939, Brisman,J.L.,et al, 2006
Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005
Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005
Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005
Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005
MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005
Adrenoleukodystrophy
JAMA 294:3131-3134, Moser,H.W.,et al, 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005
Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine
AJNR 26:695-701,687, Tardieu,M.,et al, 2005
Cerebral Infarction:Incidence and Risk Factors after Diagnostic and Interventional Cardiac Catheterization-Prospective Evaluation at Diffusion-Weighted MR Imaging
Radiology 235:177-183, Busing,K.A.,et al, 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005